<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01426594</url>
  </required_header>
  <id_info>
    <org_study_id>COL-CARDIO-NIS002</org_study_id>
    <nct_id>NCT01426594</nct_id>
  </id_info>
  <brief_title>Real-life Experience of the Use of Isomers as METPURE XL (S (-) Metoprolol Succinate) for Evaluation of Efficacy, Safety and Tolerability in the Management of Cardiovascular Disease in Colombian Patients</brief_title>
  <acronym>XPERT</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Closter Pharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Closter Pharma</source>
  <brief_summary>
    <textblock>
      This is a Phase 4, observational, open study in patients who their doctor has prescribe
      METPURE XL (S (-)metoprolol succinate)by clinical practice. No medication was provided by the
      sponsor. The planned observation time is 8 weeks. The 8 weeks of observation involves an
      evaluation of baseline followed by information gathered from the assessment visits at week 4
      and week 8.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">March 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of therapy in the management of cardiovascular diseases</measure>
    <time_frame>8 weeks</time_frame>
    <description>The objective is to mesure the effect of Metpure XL in cadiovascular diseases as hypertension, post MI and coronary disease</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate and compare the rate of compliance with treatment</measure>
    <time_frame>8 weeks</time_frame>
    <description>Evaluate the compliance with METPURE XL, to be able to identify possible reasons for noncompliance or quitting the treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Adverse Events as a Measure of Safety and Tolerability</measure>
    <time_frame>8 weeks</time_frame>
    <description>To assess the safety pattern in Colombian subjects using s(-)metoprolol succinate</description>
  </secondary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Hypertension</condition>
  <condition>Coronary Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care adults
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who were prescibed with s(-)metoprolol succinate(25mg, 50mg), depending on
             their clinical condition and use locally approved will be eligible to participate in
             this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sandra M Casiano, MD</last_name>
    <phone>57-3174049763</phone>
    <email>scasiano@closterpharma.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Harold Mejia</last_name>
    <phone>57-2264757</phone>
    <email>hmejia@closterpharma.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Country Club de Bogota</name>
      <address>
        <city>Bogota</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Andres Romero, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2011</study_first_submitted>
  <study_first_submitted_qc>August 30, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2011</study_first_posted>
  <last_update_submitted>August 30, 2011</last_update_submitted>
  <last_update_submitted_qc>August 30, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 31, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Observational</keyword>
  <keyword>Colombia</keyword>
  <keyword>Metpure XL</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

